India needs to adapt swiftly to safeguard US market presence as branded generics face the brunt of the sudden imposition of a 100% tariff on imported...
Vous n'êtes pas connecté
A sweeping new tariff on branded and patented pharmaceuticals is poised to backfire on the United States, and investors are already positioning for the fallout. The 100% duty announced by President Donald Trump, due to take effect on October 1, is designed to force drug manufacturing back onshore. Instead, it threatens to raise costs, disrupt supply chains and accelerate capital flows away from U.S. markets, according to Nigel Green, CEO of leading independent financial advisory deVere Group. “A tariff of this magnitude on high-value medicines will ripple through every part of the global health economy,” he said, warning that the
India needs to adapt swiftly to safeguard US market presence as branded generics face the brunt of the sudden imposition of a 100% tariff on imported...
Starting bOctober 1, 2025/b, US President Donald Trump will slap a b100% tariff/b on branded and patented medicines imported into America-unless the...
Starting bOctober 1, 2025/b, US President Donald Trump will slap a b100% tariff/b on branded and patented medicines imported into America-unless the...
US President Donald Trump has unveiled sweeping new tariffs that hit industries from pharmaceuticals to heavy-duty trucks, sparking fresh concerns for...
US President Donald Trump has unveiled sweeping new tariffs that hit industries from pharmaceuticals to heavy-duty trucks, sparking fresh concerns for...
A tariff tremor that reaches the lab bench: America’s 100% pharma levy and what it means for the rest of us When the announcement landed late into...
The measure appears to target the EU, the main supplier of patented medicines to the US Read Full Article at RT.com
Decision comes amid U.S. mooting exemption from proposed 100% tariff on branded and patented pharma imports for firm’s manufacturing in the country...
The US president's latest tariff move will see the US impose 100% levies on imports of branded or patented pharmaceutical goods from October 1. What...
The US president's latest tariff move will see the US impose 100% levies on imports of branded or patented pharmaceutical goods from October 1. What...